PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2007 September; 8(3): E20–E27.
Published online 2007 July 13. doi:  10.1208/pt0803054
PMCID: PMC2750550

Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen

Abstract

The aim of this work was the design of sustained-release mucoadhesive bilayered tablets, using mixtures of mucoadhesive polymers and an inorganic matrix (hydrotalcite), for the topical administration of flurbiprofen in the oral cavity. The first layer, responsible for the tablet retention on the mucosa, was prepared by compression of a cellulose derivative and polyacrylic derivative blend. The second layer, responsible for buccal drug delivery, was obtained by compression of a mixture of the same (first layer) mucoadhesive polymers and hydrotalcite containing flurbiprofen. Nonmedicated tablets were evaluated in terms of swelling, mucosal adhesion, and organoleptic characteristics; in vitro and in vivo release studies of flurbiprofen-loaded tablets were performed as well.

The best results were obtained from the tablets containing 20 mg of flurbiprofen, which allowed a good anti-inflammatory sustained release in the buccal cavity for 12 hours, ensuring efficacious salivary concentrations, and led to no irritation. This mucoadhesive formulation offers many advantages over buccal lozenges because it allows for reduction in daily administrations and daily drug dosage and is suitable for the treatment of irritation, pain, and discomfort associated with gingivitis, sore throats, laryngopharyngitis, cold, and periodontal surgery. Moreover, it adheres well to the gum and is simple to apply, which means that patient compliance is improved.

Keywords: Bilayer tablets, mucoadhesion, polyacrylic acid derivatives, cellulose derivatives, hydrotalcite, flurbiprofen, buccal delivery

Full Text

The Full Text of this article is available as a PDF (287K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Procaccini M, Mastroianni L, Orefici M. Fluribprofen colluttory in oral surgical pathology. Minerva Stomatol. 2007;45:421–425. [PubMed]
2. Ahmad N, Grad HA, Haas DA, Aronson KJ, Jokovic A, Cocker D. The efficacy of nonopioid analgesic for postoperative dental pain: a meta-analysis. Anesth Prog. 1997;44:119–126. [PMC free article] [PubMed]
3. Roszkowski MT, Swift JQ, Hargreaves KM. Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4 and (S)-flurbiprofen following extraction of impacted third molars. Pain. 1997;73:339–345. doi: 10.1016/S0304-3959(97)00120-6. [PubMed] [Cross Ref]
4. Heasman PA, Offenbacher S, Collins JG, Edwards G, Seymour RA. Flurbiprofen in the prevention and treatment of experimental gingivitis. J Clin Periodontol. 1993;20:732–738. doi: 10.1111/j.1600-051X.1993.tb00699.x. [PubMed] [Cross Ref]
5. Schachtel BP, Homan HD, Gibb IA, Christian J. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model. Clin Pharm Ther. 2002;71:375–380. doi: 10.1067/mcp.2002.124079. [PubMed] [Cross Ref]
6. Blagden M, Christian J, Miller K, Charlesworth A. Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomized, double-blind, placebo-controlled study in UK general practice centres. Int J Clin Pract. 2002;6:95–100. doi: 10.1080/136515002753724090. [PubMed] [Cross Ref]
7. Yeh KC, Frank FJ, Alfano MC. Antioxidant and arylpropionic nonsteroidal anti-inflammatory in synergistic composition for the treatment of periodontal disease 1990. Eur patent 380 367. August 1, 1990.
8. Kellaway IW, Ponchel G, Dunchene D. Oral mucosal drug delivery. In: Rathbone MJ, Hadgraft JH, Roberts MS, editors. Modified Release Drug Delivery Technology. New York, NY: Marcel Dekker; 2003. pp. 349–364.
9. Trifirò F, Vaccari A. Hydrotalcite anionic clays (layered double hydroxides) In: Alberti G, Bein T, editors. Solid State Supramolecular Chemistry. London, UK: Pergamon Elsevier Science; 2007. pp. 1–47.
10. Ambrogi V, Fardella G, Grandolini G, Perioli L, Tiralti MC. Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: uptake of diclofenac for a controlled release formulation. AAPS PharmSciTech. 2002;3:1–8. doi: 10.1208/pt030326. [PMC free article] [PubMed] [Cross Ref]
11. Peh KK, Wong CF. Polymeric films as a vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci. 1999;2:53–61. [PubMed]
12. Ritthidej GC, Phaechamud T, Koizumi T. Moist heat treatment on physicochemical change of chitosan. Int J Pharm. 2002;232:11–22. doi: 10.1016/S0378-5173(01)00894-8. [PubMed] [Cross Ref]
13. Tirosh B, Baluom M, Nassar T, Friedman M, Rubinstein A. The effect of Eudragit RL-100 on the mechanical and mucoadhesion properties of polycarbophil dosage forms. J Control Release. 1997;45:57–64. doi: 10.1016/S0168-3659(96)01545-3. [Cross Ref]
14. Han R-Y, Fang J-Y, Sung KC, Hu OYP. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm. 1999;177:201–209. doi: 10.1016/S0378-5173(98)00343-3. [PubMed] [Cross Ref]
15. Prudat-Christiaens C, Arnaud P, Allain P, Chaumeil JC. Aminophylline bioadhesive tablets attempted by wet granulation. Int J Pharm. 2007;141:109–116. doi: 10.1016/0378-5173(96)04622-4. [Cross Ref]
16. Tiwari D, Sause R, Madan PL. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci. 1999;1:1–8. doi: 10.1208/ps010313. [PMC free article] [PubMed] [Cross Ref]
17. Ali J, Khar R, Ahuja A, Kalra R. Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterization. Int J Pharm. 2002;238:93–103. doi: 10.1016/S0378-5173(02)00059-5. [PubMed] [Cross Ref]
18. Bouckaert S, Vakeat L, Remon JP. Influence of buccal application site of bioadhesive slow-release tablet on salivary miconazole concentrations in irradiated patients. Int J Pharm. 2007;130:257–260. doi: 10.1016/0378-5173(95)04301-2. [Cross Ref]
19. Costantino U, Casciola M, Massimelli L, Nocchetti M, Vivani R. Intercalation and grafting of hydrogen phosphate and phosphonates into synthetic hydrotalcites and a.c.-conductivity of the compounds thereby obtained. Solid State Ionics. 1997;97:203–212. doi: 10.1016/S0167-2738(97)00043-X. [Cross Ref]
20. Ritger PL, Peppas NA. A simple equation for description of solute release, II: Fickian and anomalous release from swellable device. J Control Release. 1987;5:37–42. doi: 10.1016/0168-3659(87)90035-6. [Cross Ref]
21. Bhaskar R, Murthy RSR, Miglani BD, Viswanathan K. Novel method to evaluate diffusion controlled release of drug from resinate. Int J Pharm. 1986;28:59–66. doi: 10.1016/0378-5173(86)90147-X. [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists